V
Market Data
$0.23−$0.47 (−66.74%)
VTGN · Last trade
Prev Close
$0.70
Range (29d)
$0.23 – $0.76
Recent Filings
- 8-K1.5 MBVistagen Therapeutics, Inc.Jun 30, 8:28 AM ET·0001628280-26-046143
- 8-K134.8 KBVistagen Therapeutics, Inc.Jun 17, 5:13 PM ET·0001628280-26-043989
- 10-K8.3 MBVistagen Therapeutics, Inc.Jun 15, 4:50 PM ET·0001628280-26-043271
- 8-K175.9 KBVistagen Therapeutics, Inc.Jun 9, 5:04 PM ET·0001628280-26-041962
- 8-K248.4 KBVistagen Therapeutics, Inc.May 19, 4:30 PM ET·0001628280-26-036492
- 8-K189.4 KBVistagen Therapeutics, Inc.May 12, 7:44 AM ET·0001628280-26-033883
- 8-K178.1 KBVistagen Therapeutics, Inc.May 8, 4:30 PM ET·0001628280-26-032935
- 8-K217.0 KBVistagen Therapeutics, Inc.Apr 28, 4:13 PM ET·0001628280-26-027930
- 8-K137.6 KBVistagen Therapeutics, Inc.Apr 13, 5:27 PM ET·0001628280-26-024943
- 8-K138.0 KBVistagen Therapeutics, Inc.Apr 2, 4:16 PM ET·0001628280-26-023176
Insiders
10- Adler Reid G.Chief Legal Officer
- Anderson Cynthia LynnCHIEF FINANCIAL OFFICER
- Angelov Angel SChief Medical Officer
- Bonfiglio Gregory A.Director
- Cato Allen Easley10% Owner
- Commodore Capital LP10% Owner
- Cote Elissa S.Chief Corp Development Officer
- Cunningham Ann MichelleDirector
- Curley JoanneDirector
- DOTSON JERROLD DUANEVP, CFO AND SECRETARY
Tickers
Addresses
business
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO, CA, 94080
mailing
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO, CA, 94080
Former Names
- Excaliber Enterprises, Ltd.2011-06-08